THE IMMUNOGEN INC. (IMGN) DOWNGRADED BY ZACKS INVESTMENT RESEARCH

(Source: DailyQuint) According to Zacks, “ImmunoGen is a development-stage biotechnology … was disclosed in a legal filing with the SEC, which is available at the SEC website.